#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA656437	F	Compound was evaluated for in vitro inhibition of [Fe(2+)]/ascorbate-induced oxidation of bovine heart membranes(antioxidant BHMLO); not determined	Bos taurus	3		organism-based format	Scientific Literature
2.	ALA690545	F	Compound was evaluated for in vitro inhibition of proliferation measured by inhibition of [3H]thymidine incorporation by HMVEC-L cells	Homo sapiens	5		cell-based format	Scientific Literature
3.	ALA830666	B	In vitro inhibitory activity against ovine cyclooxygenase-1 (COX-1) at 200 uM; Inactive		15		single protein format	Scientific Literature
4.	ALA1909163	B	DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)	Cavia porcellus	871		tissue-based format	DrugMatrix
5.	ALA1909164	B	DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)		871		cell membrane format	DrugMatrix
6.	ALA1909165	B	DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)	Oryctolagus cuniculus	871		tissue-based format	DrugMatrix
7.	ALA1909166	B	DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871		cell membrane format	DrugMatrix
8.	ALA1909167	B	DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871		cell membrane format	DrugMatrix
9.	ALA1909168	B	DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871		cell membrane format	DrugMatrix
10.	ALA1909169	B	DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)		871		cell-based format	DrugMatrix
11.	ALA1909170	B	DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
12.	ALA1909171	B	DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
13.	ALA1909172	B	DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
14.	ALA1909173	B	DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
15.	ALA1909174	B	DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)		871		cell membrane format	DrugMatrix
16.	ALA1909175	B	DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)		871		cell membrane format	DrugMatrix
17.	ALA1909176	B	DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)		871		cell membrane format	DrugMatrix
18.	ALA1909177	B	DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)		871		cell membrane format	DrugMatrix
19.	ALA1909178	B	DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)	Rattus norvegicus	871		tissue-based format	DrugMatrix
20.	ALA1909179	B	DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)	Escherichia coli	871		single protein format	DrugMatrix